IDWeek 2024 Highlights: Advancements in RSV Prevention for Children with Vaccines and Monoclonal Antibodies
Respiratory syncytial virus (RSV) continues to pose significant health risks for infants and immunocompromised individuals. At the recently concluded IDWeek 2024 in Los Angeles, pivotal studies on RSV prevention drew…
